A resource of high-quality and versatile nanobodies for drug delivery

Zhuolun Shen(University of Pittsburgh), Yufei Xiang(University of Pittsburgh), Sandra Vergara(University of Pittsburgh), Apeng Chen(University of Pittsburgh), Zhengyun Xiao(University of Pittsburgh), Ulises Santiago(University of Pittsburgh), Changzhong Jin(University of Pittsburgh), Zhe Sang(University of Pittsburgh), Jiadi Luo(University of Pittsburgh), Kong Chen(University of Pittsburgh), Dina Schneidman‐Duhovny, Carlos J. Camacho(University of Pittsburgh), Guillermo Calero(University of Pittsburgh), Baoli Hu(University of Pittsburgh), Yi Shi(University of Pittsburgh)
iScience
August 21, 2021
Cited by 39Open Access
Full Text

Abstract

-cytokine fusion constructs "Duraleukin" and demonstrated Duraleukin's high preclinical efficacy for cancer treatment in a melanoma model. This high-quality and versatile Nb toolkit will help tailor drug half-life to specific medical needs.


Related Papers

No related papers found

Powered by citation graph analysis